Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer is a research paper published in STAR Protocols (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI
Grant: /NCI U24-CA224122
NCI NIH HHS
Grant: U24 CA224122
NIAID NIH HHS
Grant: UM1 AI144288
NCI NIH HHS
Grant: K08 CA252619
NIAMS NIH HHS
Grant: R01 AR075337
National Institutes of Health
Grant: 5K08CA252619-04
Prognostic and Therapeutic Implications of IFNAR1 Signaling on CAR T Cell Therapy for Cancer
National Institutes of Health
Grant: 5U24CA224122-03
Coordinating Center for Canine Immunotherapy Trials and Correlative Studies
National Institutes of Health
Parker Institute for Cancer Immunotherapy
University of Pennsylvania
FWCI
1.13
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals